We are a leader in the development of innovative device-based solutions in permanent birth control. We manufacture and market our proprietaryEssure® permanent birth control system, which is the most effective non-surgical permanent birth control available based on a comparison of five-year clinical trial data. TheEssureprocedure delivers a soft and flexible insert into a woman’s fallopian tubes, causing a benign tissue in-growth which blocks the fallopian tubes. Successfully placedEssureinserts and the subsequent tissue growth around and through the inserts prohibits the egg from traveling through the fallopian tube, preventing conception. The effectiveness rate of theEssuresystem as determined in our clinical study is 99.83% after five years of follow-up. We obtained approval to market theEssuresystem in the European Union in February 2001 and obtained the U.S. Food and Drug Administration (“FDA”), approval for theEssuresystem in November 2002. Approximately 730,000 women worldwide have undergone theEssure procedure. We sell theEssuresystem directly in France through our wholly owned subsidiary, Conceptus SAS (“SAS”), in the United Kingdom through our wholly owned subsidiary Conceptus Medical Limited (“CML”) and in the Netherlands through our wholly owned subsidiary Conceptus B.V. (“BV”). In the rest of the world, we primarily sell indirectly through a network of distributors.
Company profile
Ticker
CPTS
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
973170244
Latest filings (excl ownership)
15-12G
Securities registration termination
17 Jun 13
25-NSE
Exchange delisting
5 Jun 13
8-K
Bayer acquires majority interest in Conceptus
5 Jun 13
8-K
Entry into a Material Definitive Agreement
5 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jun 13
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jun 13